Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Megan Bruxer

Nurse Practitioner, Gerontology Mesa, AZ Nurse Practitioner

NPI 1346987336 CMS profile 11346476

6111 E Arbor Ave, Mesa, AZ 85206

Open in the dashboard

General payments

$9,061

406 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Megan Bruxer of Mesa, AZ is reported in the CMS Open Payments database as having received $9,061 across 406 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 97th percentile of Nurse Practitioner, Gerontology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $3,265 143
2024 General $2,922 134
2023 General $2,076 96
2022 General $779 32
2021 General $18 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Megan Bruxer
  • Nurse Practitioner, Gerontology median
  • Middle half of Nurse Practitioner, Gerontology
  • National median

In program year 2025, general payments to Megan Bruxer were reported at $3,265. Among 4,139 Nurse Practitioner, Gerontology profiles paid that year, the median was $179 and the middle half received between $55 and $547.

Show as a table
Year Megan Bruxer Nurse Practitioner, Gerontology median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $18 $133 $44–$396 $132
2022 $779 $142 $48–$452 $149
2023 $2,076 $158 $53–$482 $160
2024 $2,922 $171 $55–$533 $164
2025 $3,265 $179 $55–$547 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. AstraZeneca Pharmaceuticals LP $952 41 payments
  2. Novartis Pharmaceuticals Corporation $915 48 payments
  3. Janssen Biotech, Inc. $681 33 payments
  4. Merck Sharp & Dohme Corporation $552 29 payments
  5. Pfizer Inc. $534 26 payments
  6. Daiichi Sankyo Inc. $464 19 payments
  7. Incyte Corporation $355 16 payments
  8. Regeneron Healthcare Solutions, Inc. $256 10 payments
  9. Seattle Genetics, Inc. $250 10 payments
  10. AbbVie, Inc. $233 10 payments
  11. Other $3,866 164 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $8,646 400 payments
  2. Education $414 6 payments
Products named General payments · program years 2021–2025
  1. KEYTRUDA $552 29 payments
  2. XTANDI $387 17 payments
  3. IMBRUVICA $326 14 payments
  4. ENHERTU Oncology $275 12 payments
  5. KISQALI $264 15 payments
  6. EPKINLY $258 11 payments
  7. LIBTAYO $256 10 payments
  8. ENHERTU Oncology $253 10 payments
  9. JAKAFI $251 12 payments
  10. ORGOVYX $251 13 payments
  11. Other $7,950 373 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

130

Median for Nurse Practitioner: 389

Drug cost

$26,517

Median for Nurse Practitioner: $21,885

Branded share of claims

43.8%

Median for Nurse Practitioner: 19.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 30 $23,803
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 13 $1,642
Oxycodone Hcl Generic 20 $504
Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen Brand 14 $211
Levothyroxine Sodium Generic 16 $123
Hydroxyurea Generic 11 $104
Prednisone Generic 12 $78
Levofloxacin Generic 14 $52

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 229,976 Part D prescribers listed as Nurse Practitioner; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 5 billing codes

Paid by Medicare

$2,506

Medicare's payments for the services billed

Medicare patients

47

Average age 78

Services billed

48

21 women, 26 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 51%
Ischemic heart disease 40%
Cancer 38%
Chronic kidney disease 32%
Diabetes 30%
Atrial fibrillation 23%
COPD 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

First 5 of 74 products · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ENHERTU
  • Daiichi Sankyo Inc. $169
  • AstraZeneca Pharmaceuticals LP $69
$238 — —
KEYTRUDA
  • Merck Sharp & Dohme Corporation $167
$167 — —
EPKINLY
  • Genmab U.S., Inc. $111
  • AbbVie, Inc. $28
$138 — —
IMFINZI
  • AstraZeneca Pharmaceuticals LP $106
$106 — —
KISQALI
  • Novartis Pharmaceuticals Corporation $104
$104 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

See more in the dashboard: 25 with a free account, all 74 with Patron

Records

406 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Nurse Practitioner, Gerontology in Arizona

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record